Senator John McCain (Republican, Arizona), the defeated US presidential candidate last year, has introduced legislation to authorize cheaper branded drugs from abroad, supporting a policy now adopted by the winner, President Barack Obama (Marketletters passim). The Pharmaceutical Research and Manufacturers of America (PhRMA) warned, however, that "the worldwide counterfeit threat is knocking at America's door and will soon be greeted if prescription drug importation moves forward."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze